Video by PCR via YouTube
Go to Source

Luis Ortega-Paz interviews Deepak L. Bhatt about the results of the Phase 3 Reverse-it trial which he presented during the ACC 2025 in Chicago.
According to the study, bentracimab effectively restored platelet function and achieved hemostasis in urgent surgery or major bleeding cases, with a favourable safety profile, making it a promising option for ticagrelor reversal pending regulatory review.

More info about the ACC 2025 Late Breaking Clinical Trials covered by PCRonline: https://www.pcronline.com/News/Whats-new-on-PCRonline/2025/ACC/PCR-ACC-Scientific-Sessions

#antithrombotics #coronaryinterventions #ACC25

Go to Source